# OnCo record stephen-freedland (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/stephen-freedland/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "stephen-freedland" ;
  schema:name "Stephen J. Freedland"@en ;
  schema:description "Los Angeles urologist who was lead author of EMBARK, the trial that established enzalutamide for men whose prostate cancer is returning fast after surgery or radiotherapy."@en ;
  schema:url <https://onco.cc/people/stephen-freedland/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "prostate", "trialist" ;
  schema:jobTitle "Urologist, Cedars-Sinai Cancer" ;
  onco:cancers <https://onco.cc/cancers/prostate-bcr/>, <https://onco.cc/cancers/prostate/> ;
  onco:institutions <https://onco.cc/institutions/cedars-sinai-cancer/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-embark-nejm-2023/> ;
  schema:affiliation <https://onco.cc/institutions/cedars-sinai-cancer/> .